Literature DB >> 21224801

Current controversies in colon and rectal cancer.

D M Vo1, L A Julien, A G Thorson.   

Abstract

Colon and rectal cancer is one of the leading causes of cancer death worldwide. Several areas of uncertainty remain in the screening and treatment of this disease, even though significant advances have already led to decreased rates of incidence and mortality over the last several decades. This review addresses some of the current controversies in screening for and the treatment of colorectal cancer, including specifically looking at issues related to screening modalities, local versus radical resections, protocols for adjuvant therapy and the treatment of stage IV disease.

Entities:  

Mesh:

Year:  2010        PMID: 21224801

Source DB:  PubMed          Journal:  Minerva Chir        ISSN: 0026-4733            Impact factor:   1.000


  3 in total

1.  Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.

Authors:  Behrooz Johari; Hamed Rezaeejam; Mohammad Moradi; Zahraa Taghipour; Zohreh Saltanatpour; Yousef Mortazavi; Leila Nasehi
Journal:  Mol Biol Rep       Date:  2020-08-31       Impact factor: 2.316

2.  Decreased miR-154 expression and its clinical significance in human colorectal cancer.

Authors:  Yang Kai; Cheng Qiang; Pan Xinxin; Zhou Miaomiao; Lin Kuailu
Journal:  World J Surg Oncol       Date:  2015-06-06       Impact factor: 2.754

3.  miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.

Authors:  Jun Ye; Xianguo Wu; Dang Wu; Pin Wu; Chao Ni; Zhigang Zhang; Zhigang Chen; Fuming Qiu; Jinghong Xu; Jian Huang
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.